Latest Mesoblast News & Updates

See the latest news and media coverage for Mesoblast. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Mesoblast

Biotechnology company developing allogeneic cell therapies

mesoblast.com
Headquarters
Melbourne, Australia
Founded year
2004
Company type
Public company
Number of employees
100–200

Last updated

Latest news about Mesoblast

In short: Mesoblast achieved significant revenue growth from Ryoncil sales and reached a key Phase 3 recruitment milestone for its back pain therapy trial.

Company announcements

Mesoblast

Mesoblast highlights pipeline depth at R&D Day

Discusses commercialization success in graft-versus-host disease, expansions into adult indications, and opportunities in back pain, heart failure, and pediatric inflammatory diseases.

Mesoblast

Mesoblast achieves patient recruitment target in CLBP pivotal trial

Recruitment target is reached for the pivotal trial in chronic low back pain.

Unlock all announcements with a

Media coverage

Yahoo Finance

Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Activity Report for Quarter Ended March 31, 2026 (Appendix 4C) NEW...

Unlock all articles with a

Never miss news about Mesoblast

Track Mesoblast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.